Aline Miller Principal Investigator, Professor of Biomolecular Engineering and Associate Dean for Business Engagement and Innovation, University of Manchester
Kyle Zingaro Head of Gene Therapy Process Sciences, UCB
Lindsay Davies Chief Scientific Officer, NextCell Pharma AB
Muhammad Akram Senior Medical Director, Legend Biotech
Sakis Mantalaris Don Panoz Chair of Pharmaceutical Biology & Principal Investigator, Trinity College Dublin & NIBRT
Tim Allsopp Chief Technology Officer, Laverock Therapeutics Hide Speakers All Speakers
Aisling McMahon Professor of Law, Maynooth University
Anna Nowocin Head of Flow Cytometry Standardisation, MHRA
Anton Hutter Partner, Patent Attorney, Venner Shipley IP
Charlotte Wilding Patent Attorney, Venner Shipley
Francesco Dazzi Executive Medical Lead Cell Therapies, AstraZeneca
Gabriel Kent Analytical Development Scientist, Resolution Therapeutics
John Gill Senior Director Cell Line Development, Gilead Sciences
Julia Matilainen Cell & gene Therapies Operations Lead, Hoffmann La Roche Ltd
Matthew Gibson Professor, University of Manchester
Molly Stevens Professor at Oxford University & Research Director for Biomedical Materials, Imperial College London
Nitin Garg Senior Director, PTC Therapeutics
Rolf Koehler Associate Director / Group Head, Novartis
Sarah Albon Director of Cambridge Cellular Therapy Laboratory, NHS
Sarah Snykers Head of Operations, Legend Biotech
Theodora Weisz Head of Patient Advocacy and Public Affairs EMEA, Novartis
Ulrich Dr. Rümenapp Senior Biotech Program Lead, Bayer AG
|
